CGI-43 Polyclonal Antibody

货号：ES5234
价格：面议
点击：2253

产品介绍

抗体信息

应用	WB;ELISA
反应种属	Human;Mouse;Monkey
别称	CCZ1; C7orf28A; CGI-43; Vacuolar fusion protein CCZ1 homolog; CCZ1B; C7orf28B; Vacuolar fusion protein CCZ1 homolog B; Vacuolar fusion protein CCZ1 homolog-like

【仅供科学研究使用】

相关产品:

产品名称	点击数
Anti-Isatuximab Non-Neutralizing Recombinant Antibody \|抗艾沙妥昔单抗非中和重组抗体(靶标：艾沙妥昔单抗非中和抗体)	222
Anti-Isatuximab Non-Neutralizing Recombinant Antibody \|抗艾沙妥昔单抗非中和重组抗体(靶标：艾沙妥昔单抗非中和抗体)	464
Anti-Isatuximab Neutralizing Recombinant Antibody \|抗艾沙妥昔单抗中和重组抗体(靶标：艾沙妥昔单抗中和抗体)	360
Anti-Isatuximab Neutralizing Recombinant Antibody \|抗艾沙妥昔单抗中和重组抗体(靶标：艾沙妥昔单抗中和抗体)	190
Anti-Isatuximab Neutralizing Recombinant Antibody \|抗艾沙妥昔单抗中和重组抗体(靶标：艾沙妥昔单抗中和抗体)	145
Anti-Urelumab Non-Neutralizing Recombinant Antibody \|抗乌瑞鲁单抗非中和重组抗体(靶标：乌瑞鲁单抗非中和抗体)	455
Anti-Urelumab Non-Neutralizing Recombinant Antibody \|抗乌瑞鲁单抗非中和重组抗体(靶标：乌瑞鲁单抗非中和抗体)	477
Anti-Urelumab Neutralizing Recombinant Antibody \|抗乌瑞鲁单抗中和重组抗体(靶标：乌瑞鲁单抗中和抗体)	476
Anti-Urelumab Neutralizing Recombinant Antibody \|抗乌瑞鲁单抗中和重组抗体(靶标：乌瑞鲁单抗中和抗体)	474
Anti-Urelumab Neutralizing Recombinant Antibody \|抗乌瑞鲁单抗中和重组抗体(靶标：乌瑞鲁单抗中和抗体)	421
Anti-Risankizumab Neutralizing Recombinant Antibody \|抗瑞莎珠单抗中和重组抗体(靶标：瑞莎珠单抗中和抗体)	194
Anti-Risankizumab Neutralizing Recombinant Antibody \|抗瑞莎珠单抗中和重组抗体(靶标：瑞莎珠单抗中和抗体)	312
Anti-Risankizumab Neutralizing Recombinant Antibody \|抗瑞莎珠单抗中和重组抗体(靶标：瑞莎珠单抗中和抗体)	497
Anti-Risankizumab Neutralizing Recombinant Antibody \|抗瑞莎珠单抗中和重组抗体(靶标：瑞莎珠单抗中和抗体)	166
Anti-Ranibizumab Non-Neutralizing Recombinant Antibody \|抗雷珠单抗非中和重组抗体(靶标：雷珠单抗非中和抗体)	416
Anti-Ranibizumab Non-Neutralizing Recombinant Antibody \|抗雷珠单抗非中和重组抗体(靶标：雷珠单抗非中和抗体)	293
Anti-Ranibizumab Non-Neutralizing Recombinant Antibody \|抗雷珠单抗非中和重组抗体(靶标：雷珠单抗非中和抗体)	396
Anti-Ranibizumab Neutralizing Recombinant Antibody \|抗雷珠单抗中和重组抗体(靶标：雷珠单抗中和抗体)	288
Anti-Ranibizumab Neutralizing Recombinant Antibody \|抗雷珠单抗中和重组抗体(靶标：雷珠单抗中和抗体)	376
Anti-Ranibizumab Neutralizing Recombinant Antibody \|抗雷珠单抗中和重组抗体(靶标：雷珠单抗中和抗体)	183

在线客服

QQ交谈

销售热线：
15898894496(同微信)
我要留言
周一至周五每天9:00-17:00